Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
10.1210/endo.140.11.7143 26
GLP-1 drugs linked to reduced risk of epilepsy A retrospective analysis of data from adults treated for type-2 diabetes indicates that glucose-lowering GLP-1 drugs could be linked to a lower risk of epilepsy
4 A new safety signal flagged in TRIUMPH-4 is dysaesthesia, an abnormal skin sensation that people describe as burning, tingling, or pins-and-needles
Format: Lyophilized powder
Islet-related-antibodies ICA, IAA, GADA and IA-2A were detected in 44 of the T1D children (at least one I-r-Abs), 2 children had no detectable I-r-Abs and in 4 cases I-r-Abs were not tested (Table 1)
People who combine GLP-1 therapy with consistent strength training three to four times per week consistently produce the most impressive before and after transformations
US$ 26.12
US$ 23.01
US$ 28.28
US$ 20.83
